Home LiteratureArticle Details
PMID: 22490844 Published · epublish English Journal Article

Neovascularization of coronary tunica intima (DIT) is the cause of coronary atherosclerosis. Lipoproteins invade coronary intima via neovascularization from adventitial vasa vasorum, but not from the arterial lumen: a hypothesis.

Theoretical biology & medical modelling ·Vol. 9 ·2012-04-10 ·Pages 11

Subbotin VM

Abstract

An accepted hypothesis states that coronary atherosclerosis (CA) is initiated by endothelial dysfunction due to inflammation and high levels of LDL-C, followed by deposition of lipids and macrophages from the luminal blood into the arterial intima, resulting in plaque formation. The success of statins in preventing CA promised much for extended protection and effective therapeutics. However, stalled progress in pharmaceutical treatment gives a good reason to review logical properties of the hypothesis underlining our efforts, and to reconsider whether our perception of CA is consistent with facts about the normal and diseased coronary artery. To begin with, it must be noted that the normal coronary intima is not a single-layer endothelium covering a thin acellular compartment, as claimed in most publications, but always appears as a multi-layer cellular compartment, or diffuse intimal thickening (DIT), in which cells are arranged in many layers. If low density lipoprotein cholesterol (LDL-C) invades the DIT from the coronary lumen, the initial depositions ought to be most proximal to blood, i.e. in the inner DIT. The facts show that the opposite is true, and lipids are initially deposited in the outer DIT. This contradiction is resolved by observing that the normal DIT is always avascular, receiving nutrients by diffusion from the lumen, whereas in CA the outer DIT is always neovascularized from adventitial vasa vasorum. The proteoglycan biglycan, confined to the outer DIT in both normal and diseased coronary arteries, has high binding capacity for LDL-C. However, the normal DIT is avascular and biglycan-LDL-C interactions are prevented by diffusion distance and LDL-C size (20 nm), whereas in CA, biglycan in the outer DIT can extract lipoproteins by direct contact with the blood. These facts lead to the single simplest explanation of all observations: (1) lipid deposition is initially localized in the outer DIT; (2) CA often develops at high blood LDL-C levels; (3) apparent CA can develop at lowered blood LDL-C levels. This mechanism is not unique to the coronary artery: for instance, the normally avascular cornea accumulates lipoproteins after neovascularization, resulting in lipid keratopathy. Neovascularization of the normally avascular coronary DIT by permeable vasculature from the adventitial vasa vasorum is the cause of LDL deposition and CA. DIT enlargement, seen in early CA and aging, causes hypoxia of the outer DIT and induces neovascularization. According to this alternative proposal, coronary atherosclerosis is not related to inflammation and can occur in individuals with normal circulating levels of LDL, consistent with research findings.

MeSH Terms
Adventitia/pathology Animals Biglycan/metabolism Capillary Permeability Cholesterol, Dietary/pharmacokinetics,toxicity Cholesterol, LDL/blood Coronary Artery Disease/etiology,metabolism,pathology Coronary Vessels/pathology Foam Cells/metabolism,pathology Humans Mammals/metabolism Models, Cardiovascular Neovascularization, Pathologic/complications Species Specificity Tunica Intima/metabolism,pathology Vasa Vasorum/metabolism,pathology Vasculitis/metabolism
Chemicals
BGN protein, human Biglycan Cholesterol, Dietary Cholesterol, LDL
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Subbotin Vladimir M
References (154)
154 references, click to expand
  1. [Lipids in the aqueous humor of the cattle eye and their role as potential nutritive substrates for the cornea].
    Ber Zusammenkunft Dtsch Ophthalmol Ges. 1972;71:91-5 PMID: 4679405
  2. Overexpression of heme oxygenase-1 in coronary atherosclerosis of Japanese autopsies with diabetes mellitus: Hisayama study.
    Atherosclerosis. 2009 Feb;202(2):573-81 PMID: 18620357
  3. Diffuse intimal thickening of coronary arteries in patients with coronary spastic angina.
    J Am Coll Cardiol. 2000 Aug;36(2):432-7 PMID: 10933354
  4. Evaluation of expanded polytetrafluoroethylene arteriovenous access grafts onto which microvessel-derived cells were transplanted to "improve" graft performance: preliminary results.
    Ann Vasc Surg. 1998 Sep;12(5):405-11 PMID: 9732416
  5. Translating molecular discoveries into new therapies for atherosclerosis.
    Nature. 2008 Feb 21;451(7181):904-13 PMID: 18288179
  6. The questionable role of saturated and polyunsaturated fatty acids in cardiovascular disease.
    J Clin Epidemiol. 1998 Jun;51(6):443-60 PMID: 9635993
  7. Angiogenesis occurs within the intimal proliferation that characterizes transplant coronary artery vasculopathy.
    J Heart Lung Transplant. 2005 May;24(5):551-8 PMID: 15896752
  8. Shear stress and the endothelium.
    Kidney Int Suppl. 1998 Sep;67:S100-8 PMID: 9736263
  9. Unusual idiopathic lipid keratopathy: a newly recognized entity?
    Arch Ophthalmol. 2005 Oct;123(10):1435-8 PMID: 16219739
  10. Cardiovascular safety of lumiracoxib: a meta-analysis of all randomized controlled trials > or =1 week and up to 1 year in duration of patients with osteoarthritis and rheumatoid arthritis.
    Clin Ther. 2005 Aug;27(8):1196-214 PMID: 16199245
  11. Vegetarianism, coronary disease risk factors and coronary heart disease.
    Curr Opin Lipidol. 1994 Feb;5(1):17-21 PMID: 15559026
  12. Inflammatory biomarkers and coronary heart disease: from bench to bedside and back.
    Intern Emerg Med. 2010 Jun;5(3):225-33 PMID: 20182820
  13. Proliferation, differentiation, and tube formation by endothelial progenitor cells in response to shear stress.
    J Appl Physiol (1985). 2003 Nov;95(5):2081-8 PMID: 12857765
  14. Is pathologic intimal thickening the key to understanding early plaque progression in human atherosclerotic disease?
    Arterioscler Thromb Vasc Biol. 2007 May;27(5):986-9 PMID: 17442894
  15. Investigation of Sudan IV staining areas in aortas of infants and children: possible prelesional stages of atherogenesis.
    Atherosclerosis. 2009 Sep;206(1):159-67 PMID: 19268943
  16. Distribution of intimal and medial thickening in the human right coronary artery: a study of 17 RCAs.
    Atherosclerosis. 2001 Sep;158(1):147-53 PMID: 11500185
  17. Human cytomegalovirus infection and atherothrombosis.
    J Thromb Thrombolysis. 2012 Feb;33(2):160-72 PMID: 22161772
  18. Arteriosclerosis: rethinking the current classification.
    Arch Pathol Lab Med. 2009 Aug;133(8):1309-16 PMID: 19653731
  19. Arteriosclerosis in Wild Animals in Captivity [Abstract].
    Proc R Soc Med. 1961 Nov;54(11):973 PMID: 19994143
  20. Lowering blood cholesterol to prevent heart disease. National Institutes of Health Consensus Development Conference Statement.
    Natl Inst Health Consens Dev Conf Consens Statement. 1985;5(7):27 PMID: 3887139
  21. Endothelial cell seeded dacron aortobifurcated grafts: platelet deposition and long-term follow-up.
    J Cardiovasc Surg (Torino). 1994 Oct;35(5):425-9 PMID: 7995835
  22. Intrusion through the fragile back door: immature plaque microvessels as entry portals for leukocytes and erythrocytes in atherosclerosis.
    J Am Coll Cardiol. 2009 Apr 28;53(17):1528-31 PMID: 19389563
  23. Reduction of serum LDL-C levels: a relationship to clinical benefits.
    Am J Cardiovasc Drugs. 2003;3(4):271-81 PMID: 14728080
  24. Morphogenesis of intimal thickening in nonspecific aortoarteritis.
    Hum Pathol. 1989 Nov;20(11):1048-56 PMID: 2807268
  25. Regulation of vascularization by hypoxia-inducible factor 1.
    Ann N Y Acad Sci. 2009 Oct;1177:2-8 PMID: 19845601
  26. The forgotten majority: unfinished business in cardiovascular risk reduction.
    J Am Coll Cardiol. 2005 Oct 4;46(7):1225-8 PMID: 16198835
  27. Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials.
    JAMA. 2005 Jun 1;293(21):2641-7 PMID: 15928286
  28. Pathogenesis of experimental lipid keratopathy: corneal and plasma lipids.
    Invest Ophthalmol Vis Sci. 1987 Sep;28(9):1492-6 PMID: 3623835
  29. Role of Chlamydia pneumoniae in atherosclerosis.
    Clin Sci (Lond). 2008 Apr;114(8):509-31 PMID: 18336368
  30. Intimal neovascularization in human coronary atherosclerosis: its origin and pathophysiological significance.
    Hum Pathol. 1995 Apr;26(4):450-6 PMID: 7535741
  31. Subconjunctival injection of bevacizumab in the treatment of corneal neovascularization associated with lipid deposition.
    Cornea. 2011 Jan;30(1):60-6 PMID: 20847676
  32. The role of lipid in the pathogenesis of atherosclerosis.
    Lancet. 1975 Mar 29;1(7909):724-7 PMID: 47486
  33. Normalization of high-flow or removal of flow cannot stop high-flow induced endothelial proliferation.
    Biomed Res. 2005 Feb;26(1):21-8 PMID: 15806980
  34. Proteoglycans synthesized by arterial smooth muscle cells in the presence of transforming growth factor-beta1 exhibit increased binding to LDLs.
    Arterioscler Thromb Vasc Biol. 2002 Jan;22(1):55-60 PMID: 11788461
  35. Appearance of lipid-laden intima and neovascularization after implantation of bare-metal stents extended late-phase observation by intracoronary optical coherence tomography.
    J Am Coll Cardiol. 2009 Dec 29;55(1):26-32 PMID: 20117359
  36. Atherosclerosis drug development in jeopardy: the need for predictive biomarkers of treatment response.
    Sci Transl Med. 2011 Mar 2;3(72):72cm6 PMID: 21368220
  37. Arterial wall neovascularization--potential role in atherosclerosis and restenosis.
    Jpn Circ J. 1997 Nov;61(11):893-904 PMID: 9391856
  38. Biology of disease. Atherosclerosis as a hyperplastic and/or neoplastic process.
    Lab Invest. 1983 Mar;48(3):245-55 PMID: 6338292
  39. Early atherosclerosis in humans: role of diffuse intimal thickening and extracellular matrix proteoglycans.
    Cardiovasc Res. 2008 Jul 1;79(1):14-23 PMID: 18430750
  40. Immunohistochemical study of intimal microvessels in coronary atherosclerosis.
    Am J Pathol. 1993 Jul;143(1):164-72 PMID: 7686341
  41. Fluorescein angiographic monitoring of corneal vascularization in lipid keratopathy.
    Clin Exp Ophthalmol. 2004 Feb;32(1):78-80 PMID: 14746599
  42. Phospholipid composition of aqueous humor, plasma and lens in normal and alloxan diabetic rabbits.
    Exp Eye Res. 1972 Mar;13(2):120-5 PMID: 4335243
  43. Molecular mechanisms of aortic wall remodeling in response to hypertension.
    J Vasc Surg. 2001 Mar;33(3):570-8 PMID: 11241129
  44. The hypothetical epidemic of coronary heart disease and atherosclerosis.
    Med Hypotheses. 1995 Nov;45(5):449-54 PMID: 8748084
  45. Angiogenesis and lymphangiogenesis and expression of lymphangiogenic factors in the atherosclerotic intima of human coronary arteries.
    Hum Pathol. 2005 Apr;36(4):330-40 PMID: 15891993
  46. Beta ig-h3, a transforming growth factor-beta-inducible gene, is overexpressed in atherosclerotic and restenotic human vascular lesions.
    Arterioscler Thromb Vasc Biol. 1996 Apr;16(4):576-84 PMID: 8624780
  47. Distributions of diffuse intimal thickening in human arteries: preferential expression in atherosclerosis-prone arteries from an early age.
    Virchows Arch. 2002 Sep;441(3):279-88 PMID: 12242525
  48. Hyperplastic arteriosclerosis versus atherosclerosis.
    J Am Med Assoc. 1950 Jul 8;143(10):861-5 PMID: 15421850
  49. Lipid keratopathy and atheroma.
    Trans Am Ophthalmol Soc. 1958;56:109-19; discussion 109-19 PMID: 13647588
  50. Cardiac allograft vasculopathy: real or a normal morphologic variant?
    J Heart Lung Transplant. 2007 Feb;26(2):167-73 PMID: 17258151
  51. Regulation of ATP synthase subunit e gene expression by hypoxia: cell differentiation stage-specific control.
    Am J Physiol. 1997 Feb;272(2 Pt 1):C457-65 PMID: 9124288
  52. Subnormal shear stress-induced intimal thickening requires medial smooth muscle cell proliferation and migration.
    Exp Mol Pathol. 2002 Apr;72(2):150-60 PMID: 11890724
  53. Shear stress induces endothelial differentiation from a murine embryonic mesenchymal progenitor cell line.
    Arterioscler Thromb Vasc Biol. 2005 Sep;25(9):1817-23 PMID: 15994439
  54. Recent progress in understanding atherosclerosis.
    J Am Geriatr Soc. 1983 Apr;31(4):231-5 PMID: 6833699
  55. Cholesterol drug lowers LDL-C levels but again fails to show clinical benefit.
    JAMA. 2010 Jan 20;303(3):211-2 PMID: 20085945
  56. Infection-induced coronary dysfunction and systemic inflammation in piglets are dampened in hypercholesterolemic milieu.
    Am J Physiol Heart Circ Physiol. 2011 May;300(5):H1595-601 PMID: 21357512
  57. REPORT of Committee on Nomenclature of The American Society for the Study of Arteriosclerosis; tentative classification of arteriopathies.
    Circulation. 1955 Dec;12(6):1065-7 PMID: 13270363
  58. Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia.
    J Clin Invest. 1998 Apr 15;101(8):1551-6 PMID: 9541483
  59. An elevated serum cholesterol level is secondary, not causal, in coronary heart disease.
    Med Hypotheses. 1991 Nov;36(3):238-41 PMID: 1787818
  60. Atherosclerosis: a comparative study.
    Br Med J. 1962 Feb 24;1(5277):501-7 PMID: 13893013
  61. Consensus conference. Lowering blood cholesterol to prevent heart disease.
    JAMA. 1985 Apr 12;253(14):2080-6 PMID: 3974099
  62. Chemistry of death: II. The phospholipid composition of the aqueous humour after death.
    Forensic Sci. 1977 May-Jun;9(3):229-32 PMID: 863355
  63. Arterial expression of the plasminogen activator system early after cardiac transplantation.
    Cardiovasc Res. 1997 Aug;35(2):241-9 PMID: 9349387
  64. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications.
    Circulation. 2007 Oct 16;116(16):1832-44 PMID: 17938300
  65. Thin-walled microvessels in human coronary atherosclerotic plaques show incomplete endothelial junctions relevance of compromised structural integrity for intraplaque microvascular leakage.
    J Am Coll Cardiol. 2009 Apr 28;53(17):1517-27 PMID: 19389562
  66. Treatments for corneal neovascularization: a review.
    Cornea. 2011 Aug;30(8):927-38 PMID: 21389854
  67. Nature of species differences in the medial distribution of aortic vasa vasorum in mammals.
    Circ Res. 1967 Apr;20(4):409-21 PMID: 4960913
  68. Endothelial seeding of polytetrafluoroethylene femoral popliteal bypasses: the failure of low-density seeding to improve patency.
    J Vasc Surg. 1994 Oct;20(4):650-5 PMID: 7933268
  69. A hypothesis out-of-date. the diet-heart idea.
    J Clin Epidemiol. 2002 Nov;55(11):1057-63 PMID: 12507667
  70. Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease.
    Circulation. 2006 Feb 21;113(7):929-37 PMID: 16490835
  71. Obesity, inflammation, and atherosclerosis.
    Nat Rev Cardiol. 2009 Jun;6(6):399-409 PMID: 19399028
  72. Coronary heart disease, hypercholesterolemia, and atherosclerosis. II. Misrepresented data.
    Exp Mol Pathol. 2001 Apr;70(2):120-39 PMID: 11263955
  73. Hypothetical hypercholesterolaemia and atherosclerosis.
    Med Hypotheses. 2004;62(1):72-8 PMID: 14729007
  74. A definition of the intima of human arteries and of its atherosclerosis-prone regions. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.
    Arterioscler Thromb. 1992 Jan;12(1):120-34 PMID: 1731855
  75. Lowering blood cholesterol to prevent heart disease. NIH Consensus Development Conference Statement.
    Nutr Rev. 1985 Sep;43(9):283-91 PMID: 4058807
  76. Planning primary prevention of coronary disease.
    Curr Atheroscler Rep. 2009 Jul;11(4):272-80 PMID: 19500490
  77. Analysis of arterial intimal hyperplasia: review and hypothesis.
    Theor Biol Med Model. 2007 Oct 31;4:41 PMID: 17974015
  78. Differential distribution of vasa vasorum in different vascular beds in humans.
    Atherosclerosis. 2008 Jul;199(1):47-54 PMID: 17959180
  79. Neovascularization in human atherosclerosis.
    Circulation. 2006 May 9;113(18):2245-52 PMID: 16684874
  80. Development of intimal thickening of coronary arteries over the lifetime of Atlantic salmon, Salmo salar L., fed different lipid sources.
    J Fish Dis. 2008 Jun;31(6):401-13 PMID: 18471096
  81. Atherosclerosis induced by infection with Marek's disease herpesvirus in chickens.
    Am Heart J. 1999 Nov;138(5 Pt 2):S465-8 PMID: 10539849
  82. From the bottom of the heart: anteroposterior decisions in cardiac muscle differentiation.
    Curr Opin Cell Biol. 2000 Dec;12(6):742-6 PMID: 11063942
  83. Prevention of neointimal proliferation by immunosuppression in synthetic vascular grafts.
    Eur J Cardiothorac Surg. 2001 Apr;19(4):487-92 PMID: 11306318
  84. Normal and oxidized low density lipoproteins accumulate deep in physiologically thickened intima of human coronary arteries.
    Lab Invest. 2002 Oct;82(10):1437-47 PMID: 12379778
  85. NIH Consensus Development Conference. Lowering blood cholesterol to prevent heart disease.
    Wis Med J. 1985 Oct;84(10):18-9 PMID: 4072237
  86. Corneal vascularization.
    Int Ophthalmol Clin. 1981;21(2):27-38 PMID: 6165697
  87. Flow patterns and preferred sites of intimal thickening in diameter-mismatched vein graft interpositions.
    Surgery. 2007 Jun;141(6):764-76 PMID: 17560253
  88. Idiopathic lipid corneal degeneration.
    Cornea. 1991 Mar;10(2):166-9 PMID: 1708326
  89. The concept of cause in disease.
    J Chronic Dis. 1985;38(11):947-50 PMID: 4055981
  90. The evolution of plasma cholesterol: direct utility or a "spandrel" of hepatic lipid metabolism?
    Prog Lipid Res. 2009 Mar;48(2):73-91 PMID: 19049814
  91. Lipid-laden aqueous humor associated with anterior uveitis and concurrent hyperlipemia in two dogs.
    J Am Vet Med Assoc. 1976 May 1;168(9):861-4 PMID: 177393
  92. Improvement of patency rate in heparin-coated small synthetic vascular grafts.
    Circulation. 1998 Nov 10;98(19 Suppl):II319-23; discussion II324 PMID: 9852921
  93. Coronary vasa vasorum neovascularization precedes epicardial endothelial dysfunction in experimental hypercholesterolemia.
    Cardiovasc Res. 2001 Sep;51(4):762-6 PMID: 11530109
  94. Intimal vascularization and atherosclerosis.
    J Pathol Bacteriol. 1951 Apr;63(2):201-11 PMID: 14851161
  95. Combined use of subconjunctival and intracorneal bevacizumab injection for corneal neovascularization.
    Cornea. 2011 Oct;30(10):1110-4 PMID: 21673570
  96. Use and misuse of atherosclerosis.
    J Intern Med. 1999 Mar;245(3):311 PMID: 10205595
  97. Pathogenesis of atherosclerosis.
    AJR Am J Roentgenol. 1995 Mar;164(3):553-8 PMID: 7863871
  98. Genetic variants promoting smooth muscle cell proliferation can result in diffuse and diverse vascular diseases: evidence for a hyperplastic vasculomyopathy.
    Genet Med. 2010 Apr;12(4):196-203 PMID: 20130469
  99. Intimal hyperplasia, vascular modeling, and the restenosis problem.
    Circulation. 1994 Jun;89(6):2888-91 PMID: 8205705
  100. Morphometric and immunohistochemical characterization of the intimal layer throughout the arterial system of elderly humans.
    J Anat. 2002 Jan;200(Pt 1):97-103 PMID: 11837253
  101. Mechanical strain induces specific changes in the synthesis and organization of proteoglycans by vascular smooth muscle cells.
    J Biol Chem. 2001 Apr 27;276(17):13847-51 PMID: 11278699
  102. Atherosclerosis in relation to the structure and function of the arterial intima, with special reference to th endothelium.
    Int Rev Exp Pathol. 1966;5:253-353 PMID: 4877347
  103. Atherosclerosis and angiogenesis. Its pathophysiological significance in humans as well as in an animal model induced by the gene transfer of vascular endothelial growth factor.
    Ann N Y Acad Sci. 1997 Apr 15;811:311-22; 322-4 PMID: 9186607
  104. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly.
    N Engl J Med. 1997 May 1;336(18):1276-82 PMID: 9113930
  105. Progress and challenges in translating the biology of atherosclerosis.
    Nature. 2011 May 19;473(7347):317-25 PMID: 21593864
  106. Inflammation, atherosclerosis, and coronary artery disease.
    N Engl J Med. 2005 Apr 21;352(16):1685-95 PMID: 15843671
  107. Atheroarteriosclerosis induced by infection with a herpesvirus.
    Am J Pathol. 1979 Sep;96(3):673-706 PMID: 382868
  108. Atherosclerotic plaque regression: fact or fiction?
    Cardiovasc Drugs Ther. 2010 Aug;24(4):311-7 PMID: 20549322
  109. Modulation of estrogen signaling by the novel interaction of heat shock protein 27, a biomarker for atherosclerosis, and estrogen receptor beta: mechanistic insight into the vascular effects of estrogens.
    Arterioscler Thromb Vasc Biol. 2005 Mar;25(3):e10-4 PMID: 15662019
  110. The fallacies of the lipid hypothesis.
    Scand Cardiovasc J. 2008 Aug;42(4):236-9 PMID: 18615352
  111. Early human atherosclerosis: accumulation of lipid and proteoglycans in intimal thickenings followed by macrophage infiltration.
    Arterioscler Thromb Vasc Biol. 2007 May;27(5):1159-65 PMID: 17303781
  112. Early morphologic stage of human coronary atherosclerosis.
    Kurume Med J. 1968;15(4):235-42 PMID: 5191277
  113. Consensus development summaries. Lowering blood cholesterol to prevent heart disease. National Institutes of Health.
    Conn Med. 1985 Jun;49(6):357-64 PMID: 4017584
  114. Atherosclerosis: usage and misusage.
    J Intern Med. 1998 May;243(5):395-8 PMID: 9651563
  115. Pathologic assessment of the vulnerable human coronary plaque.
    Heart. 2004 Dec;90(12):1385-91 PMID: 15547008
  116. Corneal neovascularization in contact lens wearers.
    Int Ophthalmol Clin. 1986 Spring;26(1):15-23 PMID: 2419272
  117. Vascular permeability, vascular hyperpermeability and angiogenesis.
    Angiogenesis. 2008;11(2):109-19 PMID: 18293091
  118. Primary lipid keratopathy: a morphological and biochemical assessment.
    Br J Ophthalmol. 1993 Apr;77(4):248-50 PMID: 8494863
  119. Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis).
    Trans Am Ophthalmol Soc. 2006;104:264-302 PMID: 17471348
  120. Fluid shear stress induces differentiation of Flk-1-positive embryonic stem cells into vascular endothelial cells in vitro.
    Am J Physiol Heart Circ Physiol. 2005 Apr;288(4):H1915-24 PMID: 15576436
  121. Subconjunctival and intracorneal bevacizumab injection for corneal neovascularization in lipid keratopathy.
    Cornea. 2009 Oct;28(9):1070-3 PMID: 19724199
  122. Arteriosclerosis in the African elephant. I. Intimal atherosclerosis and its possible causes.
    Atherosclerosis. 1972 Nov-Dec;16(3):307-35 PMID: 4657742
  123. Pathological vascularization of the coronary intima.
    Ciba Found Symp. 1983;100:207-21 PMID: 6197262
  124. Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia.
    Am J Pathol. 2000 Mar;156(3):965-76 PMID: 10702412
  125. Arteriosclerosis in exotic mammals.
    Atherosclerosis. 1972 Sep-Oct;16(2):225-31 PMID: 4634814
  126. A definition of the intima of human arteries and of its atherosclerosis-prone regions. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.
    Circulation. 1992 Jan;85(1):391-405 PMID: 1728483
  127. Chlamydia pneumoniae and atherosclerosis: The end?
    Can J Infect Dis Med Microbiol. 2005 Sep;16(5):267-8 PMID: 18159555
  128. Flow patterns at the major T-junctions of the dog descending aorta.
    J Biomech. 1990;23(6):537-48 PMID: 2341417
  129. Structure and function of vasa vasorum.
    Trends Cardiovasc Med. 1996 Feb;6(2):53-7 PMID: 21232275
  130. Coronary heart disease, hypercholesterolemia, and atherosclerosis. I. False premises.
    Exp Mol Pathol. 2001 Apr;70(2):103-19 PMID: 11263954
  131. Mycoplasma pneumoniae and/or Chlamydophila pneumoniae inoculation causing different aggravations in cholesterol-induced atherosclerosis in apoE KO male mice.
    BMC Microbiol. 2009 Sep 10;9:194 PMID: 19744321
  132. Treating residual cardiovascular risk: will lipoprotein-associated phospholipase A2 inhibition live up to its promise?
    J Am Coll Cardiol. 2008 Apr 29;51(17):1642-4 PMID: 18436115
  133. Cholesterol was healthy in the end.
    World Rev Nutr Diet. 2009;100:90-109 PMID: 19696531
  134. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.
    Arterioscler Thromb. 1994 May;14(5):840-56 PMID: 8172861
  135. Review and Hypothesis: Vulnerable plaque formation from obstruction of Vasa vasorum by homocysteinylated and oxidized lipoprotein aggregates complexed with microbial remnants and LDL autoantibodies.
    Ann Clin Lab Sci. 2009 Winter;39(1):3-16 PMID: 19201735
  136. Changes in metabolism of connective tissue associated with ageing and arterio- or atherosclerosis.
    J Atheroscler Res. 1962 Jan-Apr;2:50-61 PMID: 13905450
  137. Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study.
    Ann Intern Med. 1979 Jan;90(1):85-91 PMID: 217290
  138. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.
    Am J Pathol. 1995 May;146(5):1029-39 PMID: 7538264
  139. Resolution of bilateral corneal neovascularization and lipid keratopathy after photodynamic therapy with verteporfin.
    Optometry. 2011 Apr;82(4):212-4 PMID: 21216676
  140. Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies.
    Nat Med. 2002 Nov;8(11):1249-56 PMID: 12411952
  141. NIH Consensus Development Conference on lowering blood cholesterol to prevent heart disease: implications for dietitians.
    J Am Diet Assoc. 1985 May;85(5):586-8 PMID: 3989174
  142. Virus-induced atherosclerosis.
    J Exp Med. 1978 Jul 1;148(1):335-40 PMID: 209124
  143. Azithromycin for the secondary prevention of coronary events.
    N Engl J Med. 2005 Apr 21;352(16):1637-45 PMID: 15843666
  144. Blood flow through vasa vasorum of coronary arteries in atherosclerotic monkeys.
    Arteriosclerosis. 1986 May-Jun;6(3):326-31 PMID: 3707431
  145. Corneal neovascularization. Pathogenesis and inhibition.
    Cornea. 1987;6(4):250-7 PMID: 2446823
  146. The pathogenesis of atherosclerosis--an update.
    N Engl J Med. 1986 Feb 20;314(8):488-500 PMID: 3511384
  147. Arteriosclerosis in the dog. I. Spontaneous lesions in the aorta and the coronary arteries.
    AMA Arch Pathol. 1952 Apr;53(4):281-300 PMID: 14902234
  148. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.
    Circulation. 1994 May;89(5):2462-78 PMID: 8181179
  149. Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome.
    N Engl J Med. 2005 Apr 21;352(16):1646-54 PMID: 15843667
  150. Shear stress-induced release of basic fibroblast growth factor from endothelial cells is mediated by matrix interaction via integrin alpha(v)beta3.
    J Biol Chem. 2002 Jun 28;277(26):23453-8 PMID: 11976347
  151. The pathogenesis of atherosclerosis: a perspective for the 1990s.
    Nature. 1993 Apr 29;362(6423):801-9 PMID: 8479518
  152. Images in cardiovascular medicine. Optical coherence tomography findings at 5-year follow-up after coronary stent implantation.
    Circulation. 2005 Dec 6;112(23):e345-6 PMID: 16330689
  153. Why the overstated beneficial effects of statins do not resolve the cholesterol controversy.
    QJM. 2009 Jun;102(6):435-6 PMID: 19276210
  154. Shifting to new targets in pharmacological prevention of cardiovascular diseases.
    Curr Opin Lipidol. 2009 Oct;20(5):361-2 PMID: 19741336
Article Info
Journal
Theoretical biology & medical modelling
Abbr.
Theor Biol Med Model
ISSN
1742-4682
Published
2012-04-10
Epub
2012-00-10
Pages
11
Language
English
Region
England
NLM ID
101224383
PMCID
PMC3492120
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]